Fibromyalgia syndrome (FMS) is a chronic pain condition characterized by widespread pain and tenderness 1,2 . The etiology and pathophysiology of fibromyalgia are unknown and there are no effective treatments. Here we show that sensory hypersensitivity in FMS is caused by autoantibodies that act by sensitizing nociceptive sensory neurons. Administration of IgG from FMS patients increased mouse pain sensitivities to stimulation with mechanical pressure and cold. In contrast, transfer of IgG depleted samples from FMS patients or IgG from healthy control subjects had no effect on pain sensitivity. Sensory nerve fibres in ex vivo skin-nerve preparations from mice treated with FMS IgG were hypersensitive to mechanical stimulation. Immunohistochemical analysis revealed that IgG from FMS patients specifically labeled satellite glial cells and myelinated fibre tracts, as well as a small number of macrophages and endothelial cells in mouse dorsal root ganglia but not skin, muscle, spinal cord and brain. Our results demonstrate that fibromyalgia pain is caused by IgG autoantibodies that sensitize peripheral nociceptive afferents neurons and suggest that therapies that reduce patient IgG titres may be effective treatments of fibromyalgia pain.
SUMMARY
Fibromyalgia syndrome (FMS) is a chronic pain condition characterized by widespread pain and tenderness 1, 2 . The etiology and pathophysiology of fibromyalgia are unknown and there are no effective treatments. Here we show that sensory hypersensitivity in FMS is caused by autoantibodies that act by sensitizing nociceptive sensory neurons. Administration of IgG from FMS patients increased mouse pain sensitivities to stimulation with mechanical pressure and cold. In contrast, transfer of IgG depleted samples from FMS patients or IgG from healthy control subjects had no effect on pain sensitivity. Sensory nerve fibres in ex vivo skin-nerve preparations from mice treated with FMS IgG were hypersensitive to mechanical stimulation. Immunohistochemical analysis revealed that IgG from FMS patients specifically labeled satellite glial cells and myelinated fibre tracts, as well as a small number of macrophages and endothelial cells in mouse dorsal root ganglia but not skin, muscle, spinal cord and brain. Our results demonstrate that fibromyalgia pain is caused by IgG autoantibodies that sensitize peripheral nociceptive afferents neurons and suggest that therapies that reduce patient IgG titres may be effective treatments of fibromyalgia pain.
MAIN
Fibromyalgia syndrome (FMS) is a chronic pain condition characterized by widespread pain, augmented pain sensitivity to mechanical pressure and cold temperatures [3] [4] [5] , as well as fatigue and emotional distress [6] [7] [8] . The prevalence of FMS is approximately 2% 9 , and at least 80% of FMS patients are women. The prevalence rises to 10-30% among patients diagnosed with autoimmune rheumatological conditions 10, 11 , and FMS is thus one of the most common chronic pain conditions. The etiology and pathophysiology of FMS are unknown and the current treatment strategies for FMS rely mainly on life style changes, physical exercise and drug therapy with antidepressants and anticonvulsants 1 . Unfortunately, the modest efficacy of the available therapies in most patients leaves an enormous unmet clinical need. The animal models that have been used for experimental studies of FMS have uncertain translational relevance, and rely on local repeated intramuscular injections of acid 12 or systemic depletion of monoamines by reserpine treatment 13 . Consequently, the development of novel, mechanism-based therapies has been hampered by the limited understanding of the basis of FMS.
The increased polymodal pain sensitivity experienced by FMS patients 14, 15 is associated with altered pain processing in the central nervous system 2 , dysfunctional descending pain modulation 16, 17 , and structural and functional changes in the brain [18] [19] [20] . FMS is also associated with abnormalities in peripheral sensory afferents, such as spontaneous ectopic activity and sensitization of C-fibers, and loss of epidermal innervation 21, 22 . Furthermore, elevated levels of proinflammatory cytokines 23, 24 , and reduced levels of anti-inflammatory cytokines 25, 26 have been detected in FMS patients, suggesting that inflammatory processes may be engaged. These observations, together with the markedly increased prevalence of FMS among patients with autoimmune rheumatological conditions 10, 11 , led us to hypothesize that FMS may have an autoimmune basis. Here we have investigated the possibility that IgG autoantibodies cause FMS pain by examining whether sensory abnormalities can be transferred to mice by administration of IgG purified from FMS patients.
We administered IgG purified from the serum of individual FMS patients and healthy control (HC) subjects to female mice by intraperitoneal injection for 4 consecutive days (8mg per day), a dose regimen based on the original studies identifying myasthenia gravis as an autoantibody mediated disorder 27, 28 . Since FMS patients regularly report pressure hypersensitivity, we examined paw withdrawal thresholds in mice using the Randall-Selitto paw-pressure test following IgG transfer. IgG from each of the 8 patients (supplementary table 1), but not from any of the 6 healthy control subjects, rapidly produced mechanical hypersensitivity ( Fig. 1a , e, g). In addition to pressure sensitivity, patients frequently report that pain is exacerbated by cold temperatures, and quantitative sensory testing has demonstrated an increased cold pain sensitivity in FMS 4, 15 . In good agreement with patient observations, administration of IgG from FMS patients gave rise to a significantly increased sensitivity to noxious cold in mice ( Fig.1b , f, h). Both mechanical and cold hypersensitivities were established within 24-48 hours after the first injection and maintained for at least about a week after the final IgG injection. FMS IgG also generated hypersensitivity to stimulation with calibrated von Frey filaments, a widely used test of mechanical nociception in mice ( Fig. 1c ). Fibromyalgia pain is widespread, and we therefore examined the pressure sensitivity of the thigh (Fig. 1d ) using the Randall-Selitto device, to determine whether FMS IgG affects the pressure sensitivity of sites other than the hind paw in mice.
In this test, FMS IgG produced significant mechanical hypersensitivity in the thigh compared to treatment with IgG from HC. The observed hypersensitivities produced by IgG preparations from different FMS patients showed similar amplitudes ( Fig. 1e , f) and time courses, which is reflected in the plot showing the averaged mechanical and cold sensitivities produced by IgG from 8 individual FMS patients and 6 HC subjects over 10 days (Fig. 1g, h) . These results demonstrate that the transfer of sensitivities from FMS subjects to mice is reproducible across multiple FMS subject, strongly suggesting that an antibody-dependent mechanism may underlie FMS pain.
We next compared the effects of FM patient IgG with IgG-depleted patient serum to assess whether immunoglobulins and serum components other than IgG may contribute to pain and hypersensitivity in patients ( Fig.1i, l) . As expected, IgG from a single patient produced marked cold and mechanical hypersensitivities, whereas the IgG-depleted serum from the same patient was without any effect ( Fig.1i , j).
To determine whether autoantibodies are responsible for pain and painful hypersensitivities in a wider and regionally distinct cohort of FMS patients, we examined the effects of transferring IgG preparations pooled from 20 FMS patients and 20 healthy control subjects ( Supplementary table 1 ).
As expected, FMS patients displayed markedly higher pain ratings on a visual-analogue scale (VAS; Fig.   2a ) and a significantly increased pressure pain sensitivity compared to healthy control subjects ( Fig.   2b ). Administration of pooled IgG to mice (two separate experiments, each using IgG pooled from separate groups of 10 patients and 10 control subjects) significantly increased the sensitivity in the paw-pressure test compared to administration of pooled IgG from control subjects ( Fig. 2c ). In these experiments we used the same dose regimen as above (8mg of IgG on four consecutive days), but since the IgG from each individual donor was diluted 10-fold, the observed pro-nociceptive effect demonstrates that IgG from different patients have additive activity. Similar to our observations with IgG from individual patients, the pooled FMS IgG also elicited hypersensitivity to cold ( Fig. 2d ) and to stimulation with von Frey filaments ( Fig. 2e ). To determine the duration of the IgG-mediated hypersensitivity we studied mechanical thresholds in mice treated with IgG pooled from patients or control subjects for one month. The onset of mechanical hypersensitivity produced by pooled FMS IgG followed the same time course as seen with IgG from individual donors and resolved fully about 2.5 weeks after cessation of IgG administration (Fig. 2f ). This observation indicates that the painful hypersensitivities produced by FMS IgG are reversible and that sensory abnormalities resolve when the levels of pathogenic IgG are reduced sufficiently. Our results thus strongly suggest that therapies which reduce patient IgG levels may be effective treatments for FMS pain.
Sensitization of nociceptors
Microneurography studies of FMS patients have demonstrated sensitization and ectopic impulse discharge in nociceptive C-fibres 21 . To determine whether the sensory abnormalities demonstrated in mice in vivo following administration of FMS patient IgG could be explained by functional modification of peripheral nociceptors, we next examined the electrophysiological properties of single afferent nerve fibre units in skin-saphenous nerve preparations from IgG treated mice. Single units were classified according to their conduction velocity and mechanical response threshold, as described previously 29, 30 .
We stimulated the receptive fields of Aδ-and C-mechanosensitive nociceptors (AM and CM fibers) mechanically and compared the responses in preparations from mice after 4 days of treatment with IgG from either HC or FMS patients ( Fig. 3 ). Both AM and CM fibers in preparations from mice treated with FMS IgG responded to mechanical stimulation with a significantly increased number and frequency of action potentials compared to preparations from HC IgG treated mice ( Fig. 3a-d ). The increased impulse activity evoked by mechanical stimulation is consistent with the C-fibre sensitization observed in FMS patients using microneurography 21 and demonstrates that patient autoantibodies produce a heightened nociceptor activity that is maintained in the absence of the central nervous system. Since we had observed a robust behavioral cold hypersensitivity in mice treated with FMS IgG, we next examined whether this phenotype was accompanied by functional abnormalities in cold and mechanosensitive Aδ-fibres (AMCs). We used cold superfusion to identify the receptive fields of AMCs and thereafter challenged these with a 60s cooling ramp (from 32°C to 5-9°C). Cooling evoked a significantly increased number of action potentials in AMCs in preparations from mice treated with FMS IgG compared to HC IgG ( Fig.3 e, f; FMS median 82, interquartile range 41-353; HC 22, 3-52), whereas as the cold activation thresholds did not differ significantly ( Fig.3 g) .
Analysis of the temporal impulse pattern demonstrated that AMCs from FMS IgG treated mice discharged action potentials at a higher rate throughout the cooling ramp, consistent with a heightened excitability ( Fig.3 h) .
Immunohistochemical localization of human IgG
Immunohistochemical analysis of tissues from mice that had been injected with FMS IgG using antihuman IgG antibodies revealed robust staining in dorsal root ganglia (DRG; Fig. 3a ), while no specific immunoreactivity was observed in the spinal cord ( Fig.3 c, Supp. Fig. 1a ). In contrast, IgG from control subjects generated only low levels of immunoreactivity in DRGs (Fig. 3a, b ). FMS IgG was also reliably detected in DRG, but neither in brain nor spinal cord tissue by western blot analysis (Fig. 3c ). The IgG in the brain of spinal cord, these observations strongly suggest that the pronociceptive actions of FMS IgG were peripheral. Future investigations will determine whether an action of IgG on satellite cells is responsible for FMS pain and elucidate the molecular mechanisms underlying the neuronal hypersensitivities. It is clear, however, that satellite glial cells and sensory neurons can be electrically coupled and that satellite cells can influence neuronal excitability [31] [32] [33] .
Here we identify FMS as an autoimmune pathology in which IgG purified from FMS patients evokes painful hypersensitivity by sensitizing peripheral nociceptors when transferred to mice. A peripheral origin of pain and tenderness agrees well with earlier reports of peripheral sensory abnormalities in patients 5, 15, 21, 22 . A chronically heightened noxious peripheral input may be expected to generate altered patterns of activity in the CNS 20 . Identification of FMS as an autoimmune disease, rather than an unexplained functional somatic syndrome, will transform future fibromyalgia research and facilitate development of mechanism-based therapeutic interventions. Our results suggest that therapies that reduce the IgG titre in patients, or which prevent the functional consequences of the pathological IgG, will be effective therapies for fibromyalgia. 
Purification of immunoglobulins
IgG for individual testing was purified as described previously 3 
Behavioral studies
Before any nociceptive testing, mice were kept in their holding cages to acclimatize (10-15 min) to the experimental room. Mice were randomized between cages and the experimenter blinded to their treatment.
The Randall-Selitto paw-pressure test was performed using an Analgesymeter (Ugo-Basile, Italy). The experimenter lightly restrained the mouse and applied a constantly increasing pressure stimulus to the dorsal surface of the hind paw using a blunt conical probe. The nociceptive threshold was defined as the force in grams at which the mouse withdrew its paw 4 . A force cut-off value of 150 g was used to avoid tissue injury.
Tactile sensitivity was assessed using von Frey filaments (0.008-2 g) according to Chaplan's up-down was deemed an unclear response, and in such cases the stimulus was repeated. If no response was noted a higher force hair was tested and the filament producing a positive response recorded as the threshold.
Thermal sensitivity was assessed using a cold-plate (Ugo Basile, Milan). Paw withdrawal latencies were determined with the plate set at 10 °C. The animals were lightly restrained (scruffed) and the left hind paw was placed onto the surface of the plate 6, 7 . The latency to withdrawal of the paw was recorded as the endpoint. A maximum cut-off of 30 seconds was used for each paw.
Skin-nerve recording
Mice were killed by cervical dislocation and the hind paw was shaved prior to dissection of the isolated skin-nerve preparation. The saphenous nerve and the shaved skin of the hind limb were placed in a recording chamber at 32 °C. The chamber was perfused with a gassed (95% O2 and 5% CO2) prewarmed synthetic interstitial fluid (SIF): 108mM NaCl, 3.5mM KCl, 0.7mM MgSO4, 26.2mM NaCO3, 1.65mM
NaH2PO4, 1.53mM CaCl2, 9.6mM sodium gluconate, 5.55mM glucose and 7.6mM sucrose. The skin was placed inside up (corium side up) and pinned down using insect pins (0.2 mm diameter) in the organ bath to allow access to the receptive fields. The saphenous nerve was placed through a small gap from the organ bath to an adjacent recording chamber on a mirror platform. The desheathed saphenous nerve was covered with paraffin oil for electrical isolation and dissected fine nerve filaments were placed on a fine gold wire-recording electrode using a microscope 8, 9 .
Conduction velocity
The saphenous nerve was divided into progressively thinner filaments until a single unit could be isolated in response to stimulation of the receptive field with a glass rod. The electrical latency of identified units (Digitimer DS2, Digitimer Ltd, Welwyn Garden City, UK) was used to determine the conduction velocity and to categorize units as Aβ (velocity>10m/s), Aδ (1.2<velocity<10m/s) or Cfibers (0<velocity<1.2m/s).
Mechanical stimulation
A computer-controlled stimulating probe, equipped with a force transducer, was used to deliver mechanical stimuli to the most sensitive point of a receptive field (Avere Solutions UG, Erlangen, Germany). The number of action potentials elicited by stimulation with a 10s force step of 20g was determined in A-and C-mechanonociceptors (AM and CM fibers) in preparations from mice treated with FMS or HC IgG. Recording and analysis were done using Spike 2 (Cambridge Electronic Design, Cambridge, UK).
Immunofluorescence
Mice were deeply anesthetized with isoflurane and perfused with PBS, followed by 4% PFA. The lumbar spinal cord and lumbar dorsal root ganglia were collected, post fixed for 24 hours in 4% PFA, cryoprotected in 20% sucrose and then embedded in optimal cutting temperature (OCT) compound (Sakura Finetek). Tissue was sectioned with a CryoStar NX70 cryostat (Thermo Scientific) at a thickness of 10 μm and thaw mounted onto SuperFrost Plus slides (Thermo Scientific) and slides were stored at -20C until use. Prior to use slides were thawed for at least 30 minutes at room temperature and washed in PBS to remove excess OCT. Slides were blocked with PBS supplemented with 0.3% TritonX-100 and 3% normal goat or donkey serum, depending on the secondary antibody and then incubated with primary antibodies diluted in PBS supplemented with 0.1% Triton X-100 and 1% normal goat or donkey serum. Slides were washed and incubated with appropriate secondary antibodies (indicated in supplementary table 2). For colocalization studies of human IgG with various cell-type markers the primary antibodies against the cell type markers were first added and then following washing the anti-human IgG antibody was co-incubated with the secondary antibodies against cell-type markers. Following washing, the slides were incubated with DAPI (1:20000), washed again and then cover slipped with Prolong Gold mounting media (Thermo Scientific). 
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